Soluble Interleukin-2 Receptors Inhibit Interleukin 2-Dependent Proliferation and Cytotoxicity: Explanation for Diminished Natural Killer Cell Activity in Cutaneous T-Cell Lymphomas In Vivo?
- 1 January 1992
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 98 (1) , 50-54
- https://doi.org/10.1111/1523-1747.ep12494223
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Purification of the IL-2 Receptor (TAC) by Ligand-Affinity Chromatography and Utilization of the Immobilized Receptor for Receptor-Affinity Chromatography (RAC) Purification of IL-2, Mutant IL-2, and IL-2 Fusion ProteinsJournal of Investigative Dermatology, 1990
- Regulation of Alloreactivity in Vivo by a Soluble Form of the Interleukin-1 ReceptorScience, 1990
- The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound formsCell, 1989
- Mutant proteins of human interleukin 2European Journal of Biochemistry, 1989
- Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectorsEuropean Journal of Immunology, 1988
- Molecular cloning of cDNA encoding human interleukin-2 receptorNature, 1984
- Production of an Epidermal Growth Factor Receptor-Related ProteinScience, 1984
- Spontaneous release of the Leu-2 (T8) molecule from human T cells.The Journal of Experimental Medicine, 1983
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979